Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8790230 | Urologic Oncology: Seminars and Original Investigations | 2017 | 5 Pages |
Abstract
MMC injection with urethral dilatation is a safe, effective, and minimally invasive treatment option for recurrent VUAS after radical prostatectomy. Favorable long-term results can be expected even after anti-incontinence procedures.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Michael Wadih M.D., Patrick O. M.D., M.Sc., Mathieu M.D., Mazen M.D., Le Mai M.D., M.Sc.,